Unilateral Termination. Either VA or Collaborator may unilaterally terminate this CRADA (1) at any time by providing written notice in accordance with Section 13.6 at least sixty (60) days before the desired termination date; or (2) immediately upon a material breach, for good cause, for subject safety, or upon termination of the study by the FDA.
Appears in 4 contracts
Samples: www.research.va.gov, www.research.va.gov, www.research.va.gov
Unilateral Termination. Either VA or Collaborator may unilaterally terminate this CRADA (1) at any time by providing written notice in accordance with Section Article 13.6 at least sixty (60) days before the desired termination date; or (2) immediately upon a material breach, for good cause, for subject safety, or upon termination of the study by the FDA.
Appears in 3 contracts
Samples: Research and Development Agreement, License Agreement (Aveo Pharmaceuticals Inc), Research and Development Agreement
Unilateral Termination. Either VA or Collaborator may unilaterally terminate this CRADA (1) at any time by providing written notice in accordance with Section Article 13.6 at least sixty (60) days before the desired termination date; or (2) immediately upon a material breach, breach or for good cause, for subject safety, or upon termination of the study by the FDA.
Appears in 2 contracts
Samples: Research and Development Agreement, Research and Development Agreement
Unilateral Termination. Either VA or Collaborator may unilaterally terminate this CRADA (1) at any time by providing written notice in accordance with Section 13.6 Article 11.6 at least sixty (60) days before the desired termination date; or (2) immediately upon a material breach, breach or for good cause, for subject safety, or upon termination of the study by the FDA.
Appears in 2 contracts
Unilateral Termination. Either VA or Collaborator may unilaterally terminate this CRADA (1) at any time by providing written notice in accordance with Section Article 13.6 at least sixty (60) days before the desired termination date; or (2) immediately upon a material breach, for good cause, for subject safety, or upon termination of the study by the FDA.
Appears in 1 contract
Samples: ebire.org
